Recipharm in Anesthetic Patch DealBy
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has entered into a long-term agreement with Sato Pharmaceutical, a Tokyo-headquartered pharmaceutical company, for the commercial manufacture and delivery of Emla Patch, a local anesthetic product, to Japan. Emla Patch will be launched under the ethical pharmaceuticals business area at Sato.
Recipharm’s facility in Karlskoga, Sweden will produce and deliver the product to Sato. After launching in Japan, the annual volumes of Emla Patch supplied to Sato is expected to add to the present productiosn at the Karlskoga facility.